Objective: To evaluate the long term (4 years) outcomes of Eyecryl phakic intraocular lens (pIOL) implantation in myopia.
Methods: Medical records of patients, who had implantation of Eyecryl pIOL implantation were retrospectively reviewed. Patients with a follow up period of 4 years were included in the study. Refractive results, endothelial cell density, vault, and complications were evaluated.
Results: Preoperative and postoperative spherical equivalent of manifest refraction were -12.98±3.05 and -0.72±0.86 D, respectively. The efficacy index was 1.05±0.45 and safety index was 1.51±0.53. Preoperative corrected distance visual acuity (CDVA) was 0.26±0.15. Postoperative uncorrected and CDVA were 0.27±0.21 and 0.10±0.10 respectively at the last visit (4 years). The mean vault was 570±155 µ at the first month and decreased to 500±133 µ at the 4th year. Endothelial cell loss was 3.9% in the first 2 years. No significance difference was seen between 2nd and 4 years (p>0.005). No significant cataract formation was seen.
Conclusion: Eyecryl pIOL implantation for the correction of myopia may be a safe and effective surgical procedure.